影响冠心病患者冠状动脉病变支数的多因素分析
Multivariate Analysis of Coronary Artery Lesions in Patients with Coronary Heart Disease
DOI: 10.12677/ACM.2020.1011415, PDF,   
作者: 李 喆, 管甲亮*, 王永彬, 曹学雷, 黄 欢:青岛大学附属医院急诊内科,山东 青岛;术 超:青岛大学附属医院检验科,山东 青岛;王凤乔:青岛大学附属医院麻醉科,山东 青岛;张学志, 骆 锋, 周长勇:青岛大学附属医院心血管内科,山东 青岛
关键词: 冠脉介入治疗多因素分析病变支数Coronary Intervention Multivariate Analysis Number of Lesion Branches
摘要: 目的:探究影响冠心病患者冠状动脉病变支数的独立危险因素,为冠心病的预防和治疗提供理论指导。方法:选取在2016年5月1日至2018年2月28日期间于青岛大学附属医院住院接受冠状动脉介入治疗的528例患者进行研究,分为单支病变组(n = 182)、两支病变组(n = 232)、多支病变组(n = 114),应用有序Logistic回归分析方法对年龄、体重指数、吸烟史、高血压病史、糖尿病病史及血脂异常史、慢性肾功能不全、脑卒中等冠心病相关因素进行分析,探究影响冠状动脉病变支数的独立危险因素。结果:1) 两支病变、多支病变患者年龄、糖尿病病史及血脂异常史比例均高于单支病变者,差异有统计学意义(P < 0.05);多支病变患者吸烟史及高血压病史比例均高于单支病变者,差异有统计学意义(P < 0.05);不同冠脉病变支数其余各指标比较,差异无统计学意义(P > 0.05)。2) 患者冠状动脉病变支数的因素分析示两支病变、多支病变患者年龄、糖尿病病史及血脂异常史比例均高于单支病变者,差异有统计学意义(P < 0.05);多支病变患者吸烟史及高血压病史比例均高于单支病变者,差异有统计学意义(P < 0.05);不同冠状动脉病变支数其余各指标比较,差异无统计学意义(P > 0.05),进行有序Logistic回归分析结果示年龄、吸烟史、糖尿病病史及血脂异常史与患者冠状动脉病变支数独立相关(P < 0.05)。结论:性别、吸烟、糖尿病史、血脂异常史是目前冠心病患者冠状动脉病变支数的主要影响因素,尤其是男性患者,严格控制血糖、血脂、戒烟在冠心病的预防和治疗中应该得到重视,加强控制高危因素,避免或减缓冠状动脉病变的进展势在必行。
Abstract: Objective: To explore the factors affecting the number of coronary artery lesions in patients with coronary heart disease (CHD), and to provide theoretical guidance for the prevention and treatment of CHD. Methods: 528 patients who received coronary artery interventional therapy in the Affiliated Hospital of Qingdao University from May 1, 2016 to February 28, 2018 were divided into single vessel lesion group (n = 182), two vessel lesion group (n = 232) and multiple vessel lesion group (n = 114). Age, body mass index, smoking history and hypertension were studied by ordered logistic regression method. The history of diabetes mellitus, dyslipidemia, chronic renal insufficiency, stroke and other related factors of coronary heart disease were analyzed to explore the independent risk factors affecting the number of coronary artery lesions. Results: 1) The proportion of age, history of diabetes mellitus and history of dyslipidemia in two-vessel lesions, multi-vessel lesions was higher than that in single-vessel lesions (P < 0.05); the proportion of smoking history and history of hypertension in patients with multi-vessel lesions was higher than that in patients with single-vessel lesions (P < 0.05). There was no significant difference in other indicators (P > 0.05). 2) Factor analysis of the number of coronary artery lesions showed that the proportion of two-vessel lesions, age of patients with multiple-vessel lesions, history of diabetes mellitus and history of dyslipidemia was higher than that of single-vessel lesions (P < 0.05); the proportion of smoking history and history of hypertension in patients with multiple-vessel lesions was higher than that in patients with single-vessel lesions, the difference was significant (P < 0.05). Meaning (P < 0.05); there was no significant difference in the number of coronary artery lesion branches among different indexes (P > 0.05). The results of ordered multivariate logistic regression analysis showed that age, smoking history, history of diabetes mellitus and history of dyslipidemia were independently correlated with the number of coronary artery lesion branches (P < 0.05). Conclusion: Gender, smoking, diabetes mellitus and dyslipidemia are the main factors affecting the number of coronary artery lesions in patients with coronary heart disease. Especially in male patients, strict control of blood sugar, blood lipid and smoking cessation should be paid attention to in the prevention and treatment of coronary heart disease, and high-risk factors should be strengthened to avoid or slow down coronary artery disease. The progress of lesions is imperative.
文章引用:李喆, 术超, 王凤乔, 管甲亮, 王永彬, 张学志, 曹学雷, 骆锋, 黄欢, 周长勇. 影响冠心病患者冠状动脉病变支数的多因素分析[J]. 临床医学进展, 2020, 10(11): 2727-2732. https://doi.org/10.12677/ACM.2020.1011415

参考文献

[1] 严晓伟, 陈红, 高炜, 等. 中华医学会心血管病学分会专家组对于美国心脏学会和美国心脏协会2013年血胆固醇治疗指南的共识性观点[J]. 中华心血管病杂志, 2014, 42(4): 275-276.
[2] 中华医学会心血管病学分会介入心脏病学组. 中国经皮冠状动脉介入治疗指南(2016) [J]. 中华心血管病杂志, 2016, 44(5): 382-400.
[3] 李瑶, 姚思宇, 石亚君, 等. 高血压合并冠心病患者血压负荷与冠脉病变严重程度的关系研究[J]. 中国分子心脏病学杂志, 2017(4): 2144-2146.
[4] Ferrières, J. (2016) European Society of Cardiology Guidelines for the Management of Dyslipidemias. Presse Medicale, 46, 688-696. [Google Scholar] [CrossRef] [PubMed]
[5] 陈晓平, 崔兆强, 林金秀, 卢新政, 李悦, 李玉明, 李建平, 孙仰仰, 刘志浩, 刘梦苑. 《2020国际高血压学会全球高血压实践指南》解读[J]. 中国医学前沿杂志(电子版), 2020, 12(5): 54-60.
[6] 王洋, 龚燕平. 2019年ESC联合EASD对糖尿病前期、糖尿病、心血管疾病指南的解读[J]. 中国循证心血管医学杂志, 2020, 12(5): 516-518.
[7] 何权瀛, 高莹慧. 关于吸烟问题若干名词定义[J]. 中华结核和呼吸杂志, 2009(1): 26.
[8] Williams, B., Mancia, G., Spiering, W., et al. (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. Journal of Hypertension, 36, 1953-2041. [Google Scholar] [CrossRef
[9] Gensini, G.G. (1983) A More Meaningful Scoring System for Determining the Severity of Coronary Heart Disease. American Journal of Cardiology, 51, 606. [Google Scholar] [CrossRef
[10] None (2014) Comments on the ESC Guidelines on Diabetes, Prediabetes, and Cardiovascular Diseases Developed in Collaboration with the European Society for the Study of Diabetes. Revista Espaola De Cardiología, 67, 87-93. [Google Scholar] [CrossRef] [PubMed]
[11] Nicholls, S.J. and Nelson, A.J. (2019) Rivaroxaban with or without Aspirin for the Secondary Prevention of Cardiovascular Disease: Clinical Implications of the COMPASS Trial. American Journal of Cardiovascular Drugs, 19, 343-348.
[12] 姚朝阳, 田华伟, 梁爱敏. 高密度脂蛋白胆固醇与冠状动脉狭窄程度的相关性研究[J]. 中国循证心血管医学杂志, 2018(1): 91-94.
[13] Brown, W.V., Remaley, A.T. and Ridker, P.M. (2015) JCL Roundtable: Is Inflammation a Future Target in Preventing Arteriosclerotic Cardiovascular Disease. Journal of Clinical Lipidology, 9, 119-128. [Google Scholar] [CrossRef] [PubMed]
[14] 潘志然, 于海初, 葛均华, 等. 血尿酸水平对冠状动脉狭窄程度的评价价值[J]. 精准医学杂志, 2018, 33(3): 267-269, 273.
[15] Tuteja, S. and Rader, D.J. (2014) High-Density Lipoproteins in the Prevention of Cardiovascular Disease: Changing the Paradigm. Clinical Pharmacology & Therapeutics, 96, 48-56. [Google Scholar] [CrossRef] [PubMed]
[16] Namazi, N., Larijani, B. and Azadbakht, L. (2018) Dietary Inflammatory Index and Its Association with the Risk of Cardiovascular Diseases, Metabolic Syndrome, and Mortality: A Systematic Review and Meta-Analysis. Hormone & Metabolic Research, 50, 345-358. [Google Scholar] [CrossRef] [PubMed]
[17] Numasawa, Y., Kohsaka, S., Miyata, H., et al. (2015) Impact of Body Mass Index on In-Hospital Complications in Patients Undergoing Percutaneous Coronary Intervention in a Japanese Real-World Multicenter Registry. PLoS ONE, 10, e0124399. [Google Scholar] [CrossRef] [PubMed]
[18] Yang, C.S., Wang, H. and Sheridan, Z.P. (2018) Studies on Prevention of Obesity, Metabolic Syndrome, Diabetes, Cardiovascular Diseases and Cancer by Tea. Journal of Food & Drug Analysis, 26, 1-13. [Google Scholar] [CrossRef] [PubMed]
[19] 吴蕊, 杨志明. 冠心病介入治疗后再狭窄危险因素的Meta分析[J]. 中西医结合心脑血管病杂志, 2009, 7(4): 477- 478.
[20] 吴珺, 吴蕊, 王昆, 等. 229例2型糖尿病患者出院后自我管理随访调查[J]. 山西医药杂志, 2016, 45(5): 523-526.